Different distribution of plexiform lesions in primary and secondary pulmonary hypertension.

[1]  G. Simonneau,et al.  Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.

[2]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[3]  L V McIntire,et al.  Cyclical strain effects on production of vasoactive materials in cultured endothelial cells , 1992, Journal of cellular physiology.

[4]  B. Shuckett,et al.  Association of pulmonary hypertension with congenital portal hypertension in a child. , 1992, The Journal of pediatrics.

[5]  W. K. Adkins,et al.  Sustained effects of endothelin-1 on rabbit, dog, and rat pulmonary circulations. , 1991, The American journal of physiology.

[6]  D. Stewart,et al.  Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.

[7]  D. Moodie,et al.  Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. , 1991, Journal of the American College of Cardiology.

[8]  P. Braquet,et al.  Pulmonary vascular response to endothelin in rats. , 1991, Journal of applied physiology.

[9]  H. Mohri,et al.  Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study. , 1990, Thorax.

[10]  B. Madden,et al.  The ultrastructure of plexogenic pulmonary arteriopathy , 1990, The Journal of pathology.

[11]  J. Clozel,et al.  Effects of endothelin on regional blood flows in squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[12]  M. Yanagisawa,et al.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.

[13]  T. Hauth,et al.  Endothelin produces pulmonary vasoconstriction and systemic vasodilation. , 1989, Journal of applied physiology.

[14]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[15]  W. Edwards,et al.  Coexistent pulmonary and portal hypertension: morphologic and clinical features. , 1987, Journal of the American College of Cardiology.

[16]  C. Wagenvoort,et al.  Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients. , 1985, British heart journal.

[17]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[18]  C. Bloor,et al.  The Pulmonary and Bronchial Circulations in Congenital Heart Disease , 1980, Topics in Cardiovascular Disease.

[19]  D. Dhumeaux,et al.  Pulmonary hypertension complicating portal hypertension. , 1979, The American review of respiratory disease.

[20]  D. Heath,et al.  Electron microscopy of the plexiform lesion. , 1979, Thorax.

[21]  A. Fishman.  Dietary Pulmonary Hypertension , 1974, Circulation research.

[22]  C. Wagenvoort,et al.  Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .

[23]  C. Ferencz,et al.  A method for the three-dimensional study of pulmonary arteries. , 1970, Chest.

[24]  C. Carrington,et al.  Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. , 1968, The American journal of pathology.

[25]  N. Cauna.  Stammesgeschichte der Säugetiere. Eine Übersicht über Tatsachen und Probleme der Evolution der Säugetiere , 1962 .

[26]  J. Edwards,et al.  The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.

[27]  W. Brinton.  PRIMARY PULMONARY HYPERTENSION , 1950, British heart journal.

[28]  J. Fung,et al.  Reversibility of pulmonary hypertension after liver transplantation : a case report , 1993 .

[29]  T. Iijima,et al.  Structure and pathogenesis of plexiform lesion in pulmonary hypertension. , 1993, Chinese medical journal.

[30]  I. Cameron,et al.  A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. , 1992, Clinical science.

[31]  M. Yacoub,et al.  Plexiform lesion in bronchopulmonary anastomosis. , 1988, British journal of diseases of the chest.

[32]  D. Heath,et al.  Electron microscopy of hypertensive pulmonary vascular disease. , 1983, British journal of diseases of the chest.

[33]  Meyrick Bo,et al.  Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. , 1982 .

[34]  C. Wagenvoort,et al.  Pathology of pulmonary hypertension , 1977 .

[35]  D. Heath,et al.  The Human Pulmonary Circulation: Its Form and Function in Health and Disease , 1977 .

[36]  S. Widgren.  Pulmonary hypertension related to aminorex intake. Histologic, ultrastructural, and morphometric studies of 37 cases in Switzerland. , 1977, Current topics in pathology. Ergebnisse der Pathologie.

[37]  K. Benirschke,et al.  Current Topics in Pathology , 1974, Current Topics in Pathology.

[38]  D. Heath,et al.  Pulmonary vascular changes in Eisenmenger's complex. , 1959, The Journal of pathology and bacteriology.

[39]  H. Spencer.  Primary pulmonary hypertension and related vascular changes in the lungs. , 1950, The Journal of pathology and bacteriology.

[40]  G. F. Petrie.  The occurrence of typhoidal bacilluria in a horse , 1936 .